- Home
- LKFN vs IDYA Comparison
LKFN vs IDYA Comparison
Compare LKFN & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LKFN
- IDYA
- Stock Information
- Founded
- LKFN 1872
- IDYA 2015
- Country
- LKFN United States
- IDYA United States
- Employees
- LKFN N/A
- IDYA N/A
- Industry
- LKFN Major Banks
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- LKFN Finance
- IDYA Health Care
- Exchange
- LKFN Nasdaq
- IDYA Nasdaq
- Market Cap
- LKFN 1.6B
- IDYA 1.5B
- IPO Year
- LKFN 1997
- IDYA 2019
- Fundamental
- Price
- LKFN $60.41
- IDYA $21.73
- Analyst Decision
- LKFN Buy
- IDYA Strong Buy
- Analyst Count
- LKFN 2
- IDYA 12
- Target Price
- LKFN $65.00
- IDYA $54.27
- AVG Volume (30 Days)
- LKFN 111.5K
- IDYA 1.3M
- Earning Date
- LKFN 07-24-2025
- IDYA 08-05-2025
- Dividend Yield
- LKFN 3.34%
- IDYA N/A
- EPS Growth
- LKFN N/A
- IDYA N/A
- EPS
- LKFN 3.50
- IDYA N/A
- Revenue
- LKFN $236,268,000.00
- IDYA $7,000,000.00
- Revenue This Year
- LKFN $16.03
- IDYA $89.43
- Revenue Next Year
- LKFN $4.31
- IDYA $290.41
- P/E Ratio
- LKFN $17.26
- IDYA N/A
- Revenue Growth
- LKFN N/A
- IDYA N/A
- 52 Week Low
- LKFN $50.00
- IDYA $13.45
- 52 Week High
- LKFN $78.61
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- LKFN 55.39
- IDYA 65.80
- Support Level
- LKFN $58.38
- IDYA $20.46
- Resistance Level
- LKFN $60.53
- IDYA $22.25
- Average True Range (ATR)
- LKFN 1.48
- IDYA 1.04
- MACD
- LKFN -0.16
- IDYA 0.26
- Stochastic Oscillator
- LKFN 81.96
- IDYA 89.76
About LKFN Lakeland Financial Corporation
Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.